Jubilant Life Q4 net up 65% to Rs 70.68 crore

  • HTC
  • Updated: May 25, 2016 08:27 IST

NEW DELHI: Jubilant Life Sciences on Tuesday reported a 65.41% rise in consolidated net profit to Rs 70.68 crore during JanuaryMarch against a year ago. “We have delivered strong and consistent performance through the year thereby achieving our highest-ever EBITDA of Rs 1,291 crore in 2015-16,” said Shyam S Bhartia, chairman, and Hari S Bhartia, co-chairman and MD, Jubilant Life Sciences. The growth has been led by the company’s pharmaceuticals segment, specifically its speciality pharmaceuticals (sterile products) business.

also read

Blockchains that can free finance
Show comments